A three-dimensional microenvironment alters CD73 expression in cervical cancer.

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Cancer stem-like cells (CSCs) drive tumor initiation, metastasis, relapse, and therapy resistance.
• The ectoenzyme CD73 (NT5E gene) contributes to an immunosuppressive tumor microenvironment and promotes cell migration.
• Understanding CD73's role in CSCs is crucial for developing targeted cancer therapies.

Purpose of the Study:

• To investigate CD73 expression and activity in cervical cancer stem-like cells (CSCs) compared to monolayer cells.
• To analyze CD73 and purinergic signaling in CSC-like populations across various cancer types using in silico methods.
• To evaluate CD73 as a potential therapeutic target in cervical cancer.

Main Methods:

• In vitro analysis of CD73 protein expression (flow cytometry) and enzymatic activity in cervical cancer sphere-forming cells versus monolayer cells.
• In silico analysis of CD73 expression in CSC-enriched populations from seven public cancer datasets (GEO database).
• Functional assays assessing CD73 restoration upon re-plating sphere-derived cells as monolayers.

Main Results:

• In vitro studies revealed decreased CD73 protein expression and enzymatic activity in cervical cancer spheres compared to monolayers.
• CD73 expression and activity were restored when sphere-derived cells were cultured as monolayers.
• In silico analysis confirmed reduced CD73 expression in 3D spheres (cervical, thyroid, breast cancer) versus adherent counterparts.

Conclusions:

• Reduced CD73 expression in CSC-enriched populations correlates with decreased cell adhesion and tumor spreading ability.
• CD73 plays a significant role in cervical cancer progression, particularly in sphere-derived cells.
• CD73 represents a promising therapeutic target for further investigation in cervical cancer treatment.